CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin

Abstract Background The CEACAM family, a major subgroup of the carcinoembryonic antigen (CEA) family, is widely expressed in normal and neoplastic tissues. Although CEACAM6 overexpression has been reported in cholangiocarcinoma (CCA), the molecular mechanisms by which it modulates chemosensitivity i...

Descrición completa

Detalles Bibliográficos

Principais autores:	Shi‐Jia Dai, Jiang‐Qi Tan, Jia‐Qi Guo, Ya‐Nan Zhou, Teng Huang, Hao‐Lin Jiang, Yang Liu, Li‐Wei Dong, Zhen‐Gang Yuan
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-02-01
Series:	Clinical and Translational Discovery
Assuntos:	CEACAM6 cholangiocarcinoma cisplatin DNA damage ribosome biogenesis
Acceso en liña:	https://doi.org/10.1002/ctd2.70126
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!